Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

Recruiting now · Not applicable

Conditions studied: Advanced or Metastatic Cancer, Fear of Cancer Progression, Metacognition-based Intervention, Supportive-expressive Based Intervention, Psychooncology

In brief

The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.

Key facts

Study ID

NCT05679518

Run by

The University of Hong Kong

People needed

261

Starts

2023-12-20

Expected to finish

2026-06-30

Last updated by the study team

2025-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer
• are the age of 18 years or above

You may not qualify if…

• Patients with major communication difficulties
• are being unwilling or unable to commit 6 psychotherapy sessions

Where it is running

• Queen Mary Hospital-Department of Obstetrics & Gynaecology — Hong Kong, Hong Kong (enrolling)
• Queen Mary Hospital-Department of Surgery — Hong Kong, Hong Kong (enrolling)
• Queen Mary Hospital-Department of Oncology — Hong Kong, Hong Kong
• Tung Wah Hospital-Department of Surgery — Hong Kong, Hong Kong

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.